Spencer Tong

Spencer Tong is an Investment Analyst at Walleye Capital since July 2023, specializing in long/short therapeutics. Previous experience includes an Investment Internship at Aspire Capital Partners, LLC from 2021 to 2022, also focusing on long/short therapeutics, and a Fellow position at Global Founders Capital from 2020 to 2021, concentrating on early-stage therapeutics and tools. Prior to that, Spencer Tong gained experience as an Investment Intern at Daten Capital from 2019 to 2020 in long/short therapeutics. Spencer Tong holds a Doctor of Philosophy (PhD) in Medical Sciences from the University of Oxford, a Bachelor of Arts (BA) from Washington University in St. Louis, and attended Upper Canada College.